Press

For press enquires, please email

press@sanogenetics.com

Places we’ve been featured
places featured
icon pricing

Customised plans and pricing
options aligned to your objectives

A flexible approach to meet your study’s goals

pricing-image

We understand that every research project is unique, and we are dedicated to providing you with the most suitable and cost-effective solutions. 

Whether you're conducting a large-scale clinical trial, a targeted genetic study, or anything in between, our team is here to ensure that you receive the best value for your investment.

True success comes from personalised collaboration, and we begin each project by working closely with our clients to understand their research goals and create a tailored plan that fits your budget and objectives. 

From the press

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease

Sano is proud to support Neuron23 in the NEULARK Phase 2 clinical trial, a groundbreaking study exploring NEU-411, a brain-penetrant LRRK2 i.
Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus

Lupus Research Alliance Launches the DREAM Knowledge-Exchange Platform to Accelerate Precision Medicine in Lupus

Today, the Lupus Research Alliance (LRA) launched the Data Repository, Exchange, and Analytics Platform (DREAM)—a pioneering knowledge-shari.
Sano Genetics named in Bloomberg UK’s Startups to Watch 2024

Sano Genetics named in Bloomberg UK’s Startups to Watch 2024

LONDON – 22 October 2024: Sano Genetics, the UK-based precision medicine company accelerating precision medicine clinical trials, has been n.
New partnership to boost access to specialist eye care and related research for patients across the USA

New partnership to boost access to specialist eye care and related research for patients across the USA

A new partnership announced today will offer seamless, end-to-end solutions that will drive progress in both patient care and research outco.
Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics raises $11.4 million led by Plural to power precision medicine revolution with seamless trials

Sano Genetics is the only software platform tailored to running precision medicine clinical trials, leveraging AI to manage all aspects from.